Staccato® Loxapine Treatment of Schizophrenic Patients With Agitation

This study has been completed.

Sponsor:

Information provided by:

Alexza Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier:

NCT00628589

First received: February 25, 2008

Last updated: June 10, 2008

Last verified: June 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2008
Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)

No publications provided by Alexza Pharmaceuticals, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fishman R, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry. 2011 Jan;198:51-8.

To Top